Supplementary Figure S2 from Gemcitabine plus Nivolumab with Carboplatin or Oxaliplatin in Cisplatin-Ineligible Patients with Metastatic Urothelial Carcinoma: A Randomized Phase II Trial

Authors: Ziao Li, Sudeh Izadmehr, Jeannie Hoffman-Censits et al.
Publication:
Published: Unknown date
Source: Crossref
Back to Search View Original Cite This Article

Abstract

<jats:p>&lt;p&gt;Figure S2 shows Olink signatures of the two groups.&lt;/p&gt;</jats:p>

Keywords

pfigure shows olink signatures groupsp

Related Articles

On the Impossibility of Deriving Quantitative Intra-Multiplet Splittings from Symmetry-Complete Dynamics Alone

Сергей Матеров - Unknown

Read More
Global and Local influences on Egocentric Visual Perceptions of Elevation and of Verticality

Adam Shavit, Wenxun Li et al. - Unknown

Read More
From task models to world models: A person-specific computational psychology of anxiety

Paul B. Sharp, Joel G. Thomas et al. - Unknown

Read More
Where do the world’s biggest diamonds come from? Geology now has answers

Geoffrey Howarth - Unknown

Read More
From Status to Soul: Gendered Ideals and Quests for Compatibility in Contemporary Relationships

Yanwen Wang, Zheng Mu et al. - Unknown

Read More
Journal Ideas PyMinds Charcha More
PORE

About

About Us

Resources

Help Centre Research Guides CiteScore

Legal

Terms of Service Privacy Policy Cookie Policy Accessibility

Connect

Contact Us
© 2026 PORE. Content available under CC BY-NC 4.0